Full text is available at the source.
Abstract
E-MRC12a enables visual detection of as few as 1 oocyst/μL in chicken fecal samples.
- The platform integrates multiplex recombinase-aided amplification with CRISPR/Cas12a technology for simultaneous detection of all seven Eimeria species.
- The test process from sample loading to result interpretation takes 1 hour, with a total time of approximately 2 hours from initial processing to final readout.
- E-MRC12a demonstrated high specificity with no cross-reactivity among Eimeria species.
- Clinical validation showed 100% concordance with conventional diagnostic methods.
- The system is designed for field applicability, supporting epidemiological surveillance and vaccine development.
Simplified